大动脉狭窄导致细胞外血红蛋白和全身内皮功能障碍的积累
Christine Quast1, Florian Bönner1, Amin Polzin1,2
1Department of Cardiology, Pulmonology and Vascular Medicine, University Hospital and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany (C.Q., F.B., A.P., V.V., R.C., I.G.P., S.P., N.K., M. Nankinova, N.S., E.Z., J.J., F.K., J.H., S.W., K.B., P.L., S. Zako, R.E., C.J., N.G., M.M.C.-K., T.Z., M.K.).
Circulation
|June 5, 2024
概括
大动脉狭窄 (AS) 通过增加血液中的血红蛋白导致内皮功能障碍,而血红蛋白会消耗氧化 (NO). 通过导管的大动脉置换 (TAVR) 通过改善血液流动来恢复内皮功能.
科学领域:
- 心血管医学
- 血管生物学
- 血液动力学
背景情况:
- 大动脉狭窄 (AS) 可能会影响内皮功能,而不会影响传统的风险因素.
- 对于AS对全身内皮功能的直接影响尚不清楚.
研究的目的:
- 在实验性AS模型和人类队列中研究内皮和心脏功能.
- 要确定AS是否独立影响内皮功能.
主要方法:
- 使用AS小鼠模型和接受TAVR的人类AS患者.
- 通过流媒体扩张评估内皮功能,并测量血细胞外血红蛋白 (eHb) 和氧化 (NO) 消耗.
- 使用4D流动MRI,计算流体动力学和血管放松生物测试.
主要成果:
- 在小鼠和人类中引起的内皮功能障碍,与增加的eHb和NO消耗有关.
- 在AS患者中观察到升高的eHb和红细胞分裂,与内皮功能障碍相关.
- 通过降低eHb或改善血液动力学来恢复内皮功能.
结论:
- 由于血液动力学变化,AS通过增加血eHb和NO消耗,独立地促进内皮功能障碍.
- 通过正常化血流模式,TAVR减轻了NO的吸收,并改善了内皮功能.
相关概念视频
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Disorders of Hemostasis
837
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
837
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Esophageal Varices-I: Introduction
107
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
107
Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K


